Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicoboxil/nonivamide ointment for acute low back pain
2011-003890-27Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nicoboxil and nonivamide in acute lumbago (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Pain intensity difference from baseline at 8 hours after first application. Started Aug 2012; status: completed.
02
Drugs
nicoboxilnonivamide
03
Conditions
acute lumbago
Beyond the preview
Go deeper on 2011-003890-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003890-27.